Compare GRANULES INDIA with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA SUN PHARMA GRANULES INDIA/
SUN PHARMA
 
P/E (TTM) x 16.0 33.4 47.8% View Chart
P/BV x 3.1 4.7 65.8% View Chart
Dividend Yield % 0.6 0.8 67.8%  

Financials

 GRANULES INDIA   SUN PHARMA
EQUITY SHARE DATA
    GRANULES INDIA
Mar-21
SUN PHARMA
Mar-21
GRANULES INDIA/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs438654 67.0%   
Low Rs138339 40.8%   
Sales per share (Unadj.) Rs130.7139.6 93.6%  
Earnings per share (Unadj.) Rs22.29.5 233.0%  
Cash flow per share (Unadj.) Rs28.318.2 155.6%  
Dividends per share (Unadj.) Rs1.507.50 20.0%  
Avg Dividend yield %0.51.5 34.5%  
Book value per share (Unadj.) Rs86.8193.6 44.8%  
Shares outstanding (eoy) m247.672,399.34 10.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.23.6 62.0%   
Avg P/E ratio x13.052.1 24.9%  
P/CF ratio (eoy) x10.227.3 37.3%  
Price / Book Value ratio x3.32.6 129.4%  
Dividend payout %6.878.8 8.6%   
Avg Mkt Cap Rs m71,3371,190,430 6.0%   
No. of employees `000NANA-   
Total wages/salary Rs m3,24368,622 4.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,375334,981 9.7%  
Other income Rs m2698,592 3.1%   
Total revenues Rs m32,644343,573 9.5%   
Gross profit Rs m8,55241,616 20.6%  
Depreciation Rs m1,51520,800 7.3%   
Interest Rs m2631,414 18.6%   
Profit before tax Rs m7,04427,994 25.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5495,147 30.1%   
Profit after tax Rs m5,49522,847 24.0%  
Gross profit margin %26.412.4 212.6%  
Effective tax rate %22.018.4 119.6%   
Net profit margin %17.06.8 248.8%  
BALANCE SHEET DATA
Current assets Rs m19,970304,421 6.6%   
Current liabilities Rs m11,731161,456 7.3%   
Net working cap to sales %25.442.7 59.6%  
Current ratio x1.71.9 90.3%  
Inventory Days Days16149 10.9%  
Debtors Days Days86399 874.0%  
Net fixed assets Rs m17,157336,682 5.1%   
Share capital Rs m2482,399 10.3%   
"Free" reserves Rs m21,262462,229 4.6%   
Net worth Rs m21,510464,628 4.6%   
Long term debt Rs m3,4118,981 38.0%   
Total assets Rs m37,127641,103 5.8%  
Interest coverage x27.820.8 133.7%   
Debt to equity ratio x0.20 820.5%  
Sales to assets ratio x0.90.5 166.9%   
Return on assets %15.53.8 409.8%  
Return on equity %25.54.9 519.5%  
Return on capital %29.36.2 472.2%  
Exports to sales %81.90-   
Imports to sales %26.80-   
Exports (fob) Rs m26,528NA-   
Imports (cif) Rs m8,691NA-   
Fx inflow Rs m26,52884,493 31.4%   
Fx outflow Rs m8,69130,334 28.6%   
Net fx Rs m17,83754,159 32.9%   
CASH FLOW
From Operations Rs m4,32561,704 7.0%  
From Investments Rs m-2,7715,362 -51.7%  
From Financial Activity Rs m-2,993-59,805 5.0%  
Net Cashflow Rs m-1,4415,964 -24.2%  

Share Holding

Indian Promoters % 41.6 54.5 76.4%  
Foreign collaborators % 0.4 0.0 -  
Indian inst/Mut Fund % 27.2 34.5 78.8%  
FIIs % 23.2 14.4 160.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 45.5 127.5%  
Shareholders   210,785 662,384 31.8%  
Pledged promoter(s) holding % 7.0 5.6 125.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   CIPLA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    



Today's Market

Sensex Rallies 632 Points, Nifty Ends Above 16,350; Banking & IT Stocks Witness Buying(Closing)

Indian share markets rose today as easing bets about aggressive interest rate hikes by central banks lifted sentiment.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

Sun Pharma Zooms 10% as June Quarter Earnings Beat Estimates (Views On News)

Jul 30, 2021

Here's a rundown on Sun Pharma's June quarter results.

Sun Pharma's Stock Falls 4% After Its March Quarter Results (Views On News)

May 28, 2021

In the past three months, the stock has outperformed the market by gaining nearly 20%. Can it go higher?

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GRANULES INDIA SHARE PRICE


May 27, 2022 03:30 PM

TRACK GRANULES INDIA

  • Track your investment in GRANULES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GRANULES INDIA

GRANULES INDIA 5-YR ANALYSIS

COMPARE GRANULES INDIA WITH

MARKET STATS